These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23794597)

  • 1. Does smoking cessation with varenicline worsen vascular endothelial function?
    Umeda A; Kato T; Yamane T; Yano H; Ieiri T; Miyagawa K; Takeda H; Okada Y
    BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline-assisted smoking cessation decreases oxidative stress and restores endothelial function.
    Kato T; Umeda A; Miyagawa K; Takeda H; Adachi T; Toyoda S; Taguchi I; Inoue T; Node K
    Hypertens Res; 2014 Jul; 37(7):655-8. PubMed ID: 24646641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy.
    Kobayashi M; Takemoto Y; Norioka N; Iguchi T; Shimada K; Maeda M; Morimura M; Fujio Y; Azuma J; Yoshiyama M; Hirohashi K; Shuto T
    Osaka City Med J; 2015 Jun; 61(1):19-30. PubMed ID: 26434102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline augmentation in depressed smokers: an 8-week, open-label study.
    Philip NS; Carpenter LL; Tyrka AR; Whiteley LB; Price LH
    J Clin Psychiatry; 2009 Jul; 70(7):1026-31. PubMed ID: 19323966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol.
    Umeda A; Miyagawa K; Mochida A; Takeda H; Ohira Y; Kato T; Okada Y; Kotani K
    PLoS One; 2022; 17(11):e0277766. PubMed ID: 36449474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine preloading for smoking cessation: the Preloading RCT.
    Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S
    Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.